BusinessMolbio Diagnostics Stock Rises 9% After Jefferies Top Med Tech Pick
Molbio Diagnostics Ltd.'s shares surged up to 9% after Jefferies initiated coverage with a 'buy' rating and set a target price of Rs 1,600, implying a 25% gain from the last close of Rs 1,255.60. Jefferies praised Molbio as an innovation-led med-tech firm with a successful flagship platform and a strong product pipeline, expecting robust growth through FY26-29.
NDTV Business·4h ago


